Latest News: Proscia Receives FDA 510(k) Clearance For Concentriq AP-DxREAD THE PRESS RELEASE

Proscia Enhances Preclinical R&D Platform: Streamlining Pathology Workflows for Faster Drug Safety Decisions

Proscia
By Author Proscia | March 20, 2023

Proscia recently announced updates to its preclinical research and development (R&D) offerings. These improvements target the company’s flagship software platform, Concentriq® for Research, a tool many pharmaceutical companies use to manage pathology workflows and data.

Our website uses cookies. By using this site, you agree to its use of cookies.